...All right. Welcome back, everyone, to the final session of Guggenheim's I&I Conference. My name is Eddie Hickman. I'm one of the biotech analysts here. And I'm joined today by some of the ACADIA management team, CFO, Mark Schneyer; and Doug Williamson, the Head of R&D. Welcome, gentlemen. Mark, do you maybe want to give -- spend 5 minutes giving us a quick overview of the company? And maybe you just recently reported earnings. So maybe just give us a summary of what you saw on some of the programs that are going ahead. Mark C. Schneyer ...